<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="0" ids="7640">Nortriptyline</z:chebi>, an antidepressant, was identified as a strong inhibitor of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition by our screening of a library of 1040 drugs </plain></SENT>
<SENT sid="1" pm="."><plain>Because <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition and consequent <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction have been implicated in <z:hpo ids='HP_0011009'>acute</z:hpo> neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, we proposed to investigate the possible neuroprotective effects of <z:chebi fb="0" ids="7640">nortriptyline</z:chebi> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The effects of <z:chebi fb="0" ids="7640">nortriptyline</z:chebi> were first studied in oxygen/<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation-induced <z:hpo ids='HP_0011420'>death</z:hpo> of primary cerebrocortical neurons, a cellular model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> membrane potential, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> factor release, and caspase 3 activation were evaluated after its treatment </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="7640">Nortriptyline</z:chebi> was also studied in a mouse model, which was established by occlusion of the middle cerebral artery </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neurological function, and biochemical events were examined in the absence or the presence of <z:chebi fb="0" ids="7640">nortriptyline</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="0" ids="7640">Nortriptyline</z:chebi> inhibits oxygen/<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation-induced cell <z:hpo ids='HP_0011420'>death</z:hpo>, loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential, downstream release of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> factors, and activation of caspase 3 in primary cerebrocortical neurons </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, it decreases <z:mpath ids='MPATH_124'>infarct</z:mpath> size and improves neurological scores after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in mice </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The ability of <z:chebi fb="0" ids="7640">nortriptyline</z:chebi> to inhibit <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> factor release and caspase activation and further protect the animals correlates to its inhibitory effect on <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition in isolated mitochondria </plain></SENT>
<SENT sid="9" pm="."><plain>This study indicated that <z:chebi fb="0" ids="7640">nortriptyline</z:chebi> is neuroprotective against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>It also suggested <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition might be a valuable therapeutic target for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
</text></document>